MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.arth.2025.10.068

Медицинская библиотека · The Journal of arthroplasty · 2025

The Impact of Bone Marrow Transplant on Total Joint Arthroplasty Outcomes in Patients Diagnosed With Multiple Myeloma.

Rainwater Randall R, Siebenmorgen Jacob P, Mears Simon C, Stronach Benjamin M, Barnes C Lowry, Stambough Jeffrey B

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

As screening and treatment for multiple myeloma (MM) improve, 5-year survival rates continue to rise. Bone marrow transplant (BMT) remains a challenging, but effective therapy with lasting benefit. Although postoperative outcomes after total joint arthroplasty (TJA) are well-studied in solid organ transplant recipients, data for BMT recipients are limited. This study aimed to define the impact of BMT on 90-day TJA outcomes.

METHODS

We used a large national insurance database to compare postsurgical complications in MM patients who underwent TJA, with or without prior BMT. A retrospective database review assessed differences in demographics, perioperative complications, readmissions, and postoperative risks. Perioperative outcomes were compared using multivariate analysis.

RESULTS

The BMT recipients undergo TJA at a younger age (total hip arthroplasty (THA): 61 versus 68 years, total knee arthroplasty (TKA): 66 versus 69 years). The BMT recipients do not have a higher risk of periprosthetic joint infection (THA: P = 0.32; TKA: P = 0.3), periprosthetic fracture (THA: P = 0.9; TKA: P = 0.98), or prosthetic instability (THA: P = 1; TKA: P = 1) within 90 days of TJA. However, BMT recipients have higher rates of pathological fractures (THA: odds ratio (OR): 0.92; TKA: OR: 1.73). All-cause 90-day readmission rates are similar, but BMT recipients have increased odds of thromboembolic events after TJA (THA: OR 2.12, TKA OR: 1.19).

CONCLUSIONS

Prior BMT does not increase prosthetic complications in MM patients undergoing hip or knee arthroplasty but is associated with higher risks of thromboembolic events and pathological fractures within 90 days of TJA, warranting careful perioperative management.

Для цитирования: Rainwater Randall R, Siebenmorgen Jacob P, Mears Simon C, Stronach Benjamin M, Barnes C Lowry, Stambough Jeffrey B. The Impact of Bone Marrow Transplant on Total Joint Arthroplasty Outcomes in Patients Diagnosed With Multiple Myeloma.. The Journal of arthroplasty. 2025. DOI: 10.1016/j.arth.2025.10.068.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.